Contribution of limbic norepinephrine to cannabinoid-induced aversion
RATIONALE: The cannabinoid system has risen to the forefront in the development of novel treatments for a number of pathophysiological processes. However, significant side effects have been observed in clinical trials raising concerns regarding the potential clinical utility of cannabinoid-based age...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2010
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/29625 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/29625 |